emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Genus / Sergal Gestió Ramadera

No EMAT : 116109
Announced Date : 28/06/2021
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Genus

Target : Sergal Gestió Ramadera
Country : Spain
Sector of activity :
  • Health, Pharmaceuticals & Biotechnology > Biotechnology
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Founded in 2011 by Albert Noguera and Sergi Armengol, Sergal Gestió Ramadera, S.L. is an independent genetic production and distribution company of semen in Spain . > Today, Sergal has close to 500...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current ns ns ns
Rating : ***
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biotechnology » = 42
  • Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
23/02/2017 Genus Hermitage Genetics Designated Activity Company Ireland ** 116100
13/03/2024 Advanced Medical Solutions Group Peters Surgical Hauts-De-Seine *** 116034

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report